SciSparc Ltd. Gains 78.03%
SciSparc Ltd. (SPRC:NASDAQ) soared at $6.16, a gain of 78%. On Wed, Jan 24, 2024, SPRC:NASDAQ hit a New 2-Week High of $6.16. The stock appeared on our News Catalysts scanner on Wed, Jan 24, 2024 at 10:51 AM in the 'AGREEMENT' category. From Thu, Jan 11, 2024, the stock recorded 50.00% Up Days and 44.44% Green Days
The stock spiked on Fri, Nov 24, 2023 at $14.22 with a volume of 17M+.
About SciSparc Ltd. (SPRC:NASDAQ)
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field.
Top 10 Gainers:
- Evaxion Biotech A/S (EVAX:NASDAQ), 113.43%
- VS Media Holdings Limited (VSME:NASDAQ), 97.87%
- SciSparc Ltd. (SPRC:NASDAQ), 78.03%
- Getaround Inc. (GETR:NYSE), 76.28%
- CCSC Technology International Holdings Limited (CCTG:NASDAQ), 52.25%
- Kura Oncology, Inc. (KURA:NASDAQ), 46.13%
- Alaunos Therapeutics Inc Com (TCRT:NASDAQ), 45.18%
- Inhibikase Therapeutics Inc. (IKT:NASDAQ), 37.67%
- Esports Technologies Inc. (EBET:NASDAQ), 33.16%
- Akso Health Group (AHG:NASDAQ), 31.89%